Table II.
Complex nature of coexisting indications for OKT3 therapy in group 1 patients
Indication | Number of patients |
---|---|
Renal failure alone | 0 |
Renal failure plus primary graft dysfunction | 2 |
Renal failure plus rejection | 3 |
Primary graft dysfunction alone | 1 |
Primary graft dysfunction plus rejection | 3 |
Rejection alone | 6 |
Renal failure, primary graft dysfunction plus rejection | 3 |
Total | 18 |